RE: They don't have what xenoview mri provides12 Aug 2024 09:15
Yes the two de novo systems came before trial conversions but it's all the razor and blade scenario for repeat ongoing revenue building whether de novo or trial conversion to clinical same ongoing revenue from scans. Yes more de novo will come as will trial conversions and fresh sales like de novo are the peak of confidence boost and plenty of revenue from machine purchases. 6 month Results next month will shed light on where we are headed this year. If we're not between 3-5p by end of 2024 financial year I'll eat my hat or my words